Communiqués de presse

Emerald Health Therapeutics Announces Discharge of Litigation
VANCOUVER, British Columbia , Jan. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) announced today that its wholly-owned subsidiary, Verdélite Sciences Inc. (“Verdélite”), which operates a 75,000 square foot indoor cannabis cultivation facility in
Jan. 30, 2019
Formats Additionnels
Affichage 41 - 48 sur 48